Huang Wenyong, Xie Jianlan, Xu Xiao, Gao Xue, Xie Ping, Zhou Xiaoge
Department of Pathology, Beijing Friendship Hospital of Capital Medical University Beijing 100050, China ; Department of Pathology, The First Affiliated Hospital of Jiujiang University Jiujiang, China.
Department of Pathology, Beijing Friendship Hospital of Capital Medical University Beijing 100050, China.
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11372-8. eCollection 2015.
MUM1 is a member of the interferon regulatory factor family of transcription factors. It is normally expressed in plasma cells, late B cells, and activated T cells, and has been described in several B-cell malignancies and some T-cell neoplasms. The aim of our study was to evaluate the role of MUM-1/IRF4 protein in differentiating angioimmunoblastic T cell lymphoma (AITL) with Hodgkin/Reed-Sternberg (HRS)-like cells from cHL. We identified 12 cases of AITL with HRS-like cells and 24 cases of cHL from March 2013 to November 2014. IHC for MUM-1/IRF4 protein was performed on the tissue of these cases and some relevant positive and negative controls. MUM-1 was expressed in HRS-like cells and some neoplastic T-cells in AITL with HRS-like cells (12/12, 100%) and formed the rosettes around the HRS-like cells (12/12, 100%), expressed in HRS cells in classic Hodgkin Lymphoma (cHL) (24/24, 100%) and just one case formed rosettes around the HRS cells (1/24, 4.2%). Based on the results, MUM-1 could be a useful marker for the differential diagnosis between AITL with HRS-like cells and cHL.
MUM1是转录因子干扰素调节因子家族的成员。它通常在浆细胞、晚期B细胞和活化T细胞中表达,并且在几种B细胞恶性肿瘤和一些T细胞肿瘤中也有报道。我们研究的目的是评估MUM-1/IRF4蛋白在鉴别伴有霍奇金/里德-斯腾伯格(HRS)样细胞的血管免疫母细胞性T细胞淋巴瘤(AITL)与经典型霍奇金淋巴瘤(cHL)中的作用。我们在2013年3月至2014年11月期间鉴定出12例伴有HRS样细胞的AITL病例和24例cHL病例。对这些病例的组织以及一些相关的阳性和阴性对照进行了MUM-1/IRF4蛋白的免疫组化检测。MUM-1在伴有HRS样细胞的AITL的HRS样细胞和一些肿瘤性T细胞中表达(12/12,100%),并在HRS样细胞周围形成玫瑰花结(12/12,100%);在经典型霍奇金淋巴瘤(cHL)的HRS细胞中表达(24/24,100%),但仅1例在HRS细胞周围形成玫瑰花结(1/24,4.2%)。基于这些结果,MUM-1可能是鉴别伴有HRS样细胞的AITL与cHL的有用标志物。